{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-047180","form_type":"8-K","ticker":null,"cik":"0001708331","company_name":"Virpax Pharmaceuticals, Inc.","filed_at":"2023-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.145745+00:00","generated_at":"2026-06-14T05:55:44.826293+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Virpax realigns board classes: Ruskin moves to Class I; quorum cut to 34%","bullets":["Director Barbara Ruskin resigned from Class III and was appointed to Class I, effective June 5, 2023.","Her term now extends to the 2025 annual meeting (previously 2024).","Bylaws amended to reduce quorum requirement to 34% of voting power at stockholder meetings."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-047180","json":"https://secwatch.observer/filing/0001213900-23-047180.json","markdown":"https://secwatch.observer/filing/0001213900-23-047180.md","text":"https://secwatch.observer/filing/0001213900-23-047180.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708331/000121390023047180/0001213900-23-047180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708331/000121390023047180/ea179780-8k_virpaxpharm.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:55:44.826293+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eaf81b1f7e6bd60e4ba5eb0837f0c24e0a43326d","claim":"Virpax Pharmaceuticals, Inc.: Amended quorum requirement to 34% voting power of shares issued and entitled to vote (effective 2023-06-05).","evidence_excerpt":"On June 5, 2023, the Company’s Board of Directors amended the Company’s by-laws, effective immediately in order to amend the quorum requirement of ninth paragraph of Article I, Section 1.6 of the by-laws, such that thirty-four percent (34%) in voting power of shares of the capital stock of the Company issued and entitled to vote at the meeting, present in person or present by means of remote communication in a manner, if any , shall constitute a quorum for the transaction of business at all meetings of the stockholders.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000121390023047180/0001213900-23-047180-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-06-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}